| http://www.w3.org/ns/prov#value | - After a year of treatment, significant differences were seen between the methotrexate monotherapy and combination groups on multiple endpoints, including tender joint counts, patient and physician global assessments, pain, CRP, erythrocyte sedimentation rate, disease activity scores in 28 joints, and health assessment questionnaire (P<0.001 for all).
|
